Michael Owen

Dr. Michael J.
Owen is a Chairman at Ossianix, Inc., a Member at European Molecular Biology Organization, a Member at The European Molecular Biology Laboratory and a Senior Independent Director at Avacta Life Sciences Ltd. He is on the Board of Directors at Novalgen Ltd., Sareum Holdings Plc, ReNeuron Ltd., Gammadelta Therapeutics Ltd., Ossianix Uk Ltd., The Club Cricket Organisation Ltd. and Avacta Life Sciences Ltd. Dr. Owen was previously employed as an Independent Non-Executive Director by ReNeuron Group Plc, a Senior Independent Director by Avacta Group Plc, an Independent Director by Zealand Pharma A/S, a Chief Scientific Officer by Kymab Ltd., a Senior VP & Head-Biopharmaceuticals Research by GlaxoSmithKline Plc, a Member by Apollo Therapeutics No.
2 LLP, a Non-Executive Director by BliNK Therapeutics Ltd., and a Non-Executive Director by Istesso Ltd. He also served on the board at BliNK Biomedical SAS and Iksuda Therapeutics Ltd. He received his graduate degree from the University of Oxford and a doctorate degree from the University of Cambridge.